Ashkon Software



ENZY - Enzymotec Ltd.

Enzymotec Ltd. logoEnzymotec Ltd. is a biotech company focused on the research, development, and production of bio-active lipid-based compounds and nutritional ingredients. The company has three business segments: Nutrition, Pharma, and VAYA Pharma.

The Nutrition segment develops and markets lipid-based nutritional ingredients and medical foods that address a range of health conditions, including cognitive, cardiovascular, and metabolic health. The Pharma segment is focused on developing drugs for the treatment of neurodegenerative and metabolic diseases. The VAYA Pharma segment is engaged in the development, manufacture, and marketing of products based on lipid-based compounds that have therapeutic benefits.

Enzymotec was founded in 1998 and is headquartered in Israel. The company's products are sold worldwide through a network of distributors and strategic partners.

In 2018, Enzymotec was acquired by Frutarom, a flavor and fragrance company, for $290 million. Since then, Enzymotec has operated as a subsidiary of Frutarom.

Enzymotec's products have received a number of awards and recognitions. For example, its Sharp PS Gold product, which is used in dietary supplements for cognitive health, won the NutrAward for Best New Ingredient at the 2012 Natural Products Expo West.

The company has also been recognized for its sustainability efforts. In 2016, Enzymotec was included in the FTSE4Good Index, which is a global index of companies that meet environmental, social, and governance criteria.




Copyright © 2000-2023, Ashkon Software LLC
Privacy Policy | Refund Policy | Disclaimer